Check eligibility
A randomized, phase 3 trial of naltrexone SR/bupropion SR for weight loss in obesity
Patients receive thorough evaluations, ongoing monitoring, and lifestyle guidance to support sustainable weight loss using FDA-cleared oral semaglutide as part of a comprehensive approach
GLP-1 Maintenance Is Not One Decision Patients often ask, Do I have to stay on GLP-1 medication forever? The better answer is that maintenance is not one decision
However, as of now, the FDA has approved GLP-1 drugs only in the form of injections and pills 1 , 2 , and there are no approved form of GLP-1 transdermal (skin) patches which are in medical use
Common areas affected after GLP-1 weight loss: Face & Neck: Jowls, sagging cheeks, loose neck skin Breasts: Loss of volume and firmness Upper Arms: Bat wings from skin hanging under the triceps Abdomen & Flanks: Skin overhang or apron belly Buttocks & Thighs: Flattened or deflated contours The Problem of Skin Excess After Massive Weight Loss Whether weight loss is achieved through medication, lifestyle changes, or bariatric surgery, the skin often does not shrink back to match the new body contours